Novel use of riociguat in infants with severe pulmonary arterial hypertension unable to wean from inhaled nitric oxide

• Main Authors: L. T. Domingo (Author), D. D. Ivy (Author), S. H. Abman (Author), A. M. Grenolds (Author), J. T. MacLean (Author), J. A. Breaux (Author), K. J. Minford (Author), B. S. Frank (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

IntroductionRiociguat, an oral soluble guanylate cyclase stimulator, has been approved for use in adults with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension. However, there is limited data on its therapeutic use in children.Case PresentationWe report the case...